Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SHE:300357)

SHE:300357 Revenue

Zhejiang Wolwo Bio-Pharmaceutical had revenue of 369.12M CNY in the quarter ending September 30, 2025, with 22.64% growth. This brings the company's revenue in the last twelve months to 1.05B, up 15.90% year-over-year. In the year 2024, Zhejiang Wolwo Bio-Pharmaceutical had annual revenue of 925.39M with 9.10% growth.

• Revenue (ttm): 1.05B
• Revenue Growth: +15.90%
• P/S Ratio: 13.86
• Revenue / Employee: 624.49K
• Employees: 1,679
• Market Cap: 14.53B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	925.39M	77.20M	9.10%
Dec 31, 2023	848.19M	-47.83M	-5.34%
Jan 1, 2023	896.02M	88.32M	10.94%
Dec 31, 2021	807.69M	171.48M	26.95%
Dec 31, 2020	636.21M	-3.14M	-0.49%